FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension
Status: Resolved
»Duration of Shortage: 01/22/2018 - 10/07/2020
»Therapeutic Categories: Pediatric; Psychiatry

Expand all

Tris Pharma, Inc. (Revised 10/07/2020)

Company Contact Information:
732-940-0358

Presentation
  • 300 mg/60 mL (NDC 24478-321-02)
  • 600 mg/120mL (NDC 24478-322-04)
  • 750 mg/150 mL (NDC 24478-323-05)
  • 900 mg/180 mL (NDC 24478-324-06)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English